Profile | GDS5420 / 214245_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 32.25 | 25 |
GSM1296119 | B_lesional_pre-dose | 45.42 | 27 |
GSM1296076 | C_lesional_pre-dose | 62.84 | 35 |
GSM1296092 | D_lesional_pre-dose | 74.42 | 39 |
GSM1296103 | E_lesional_pre-dose | 52.05 | 32 |
GSM1296078 | F_lesional_pre-dose | 103.05 | 43 |
GSM1296107 | G_lesional_pre-dose | 56.77 | 31 |
GSM1296109 | H_lesional_pre-dose | 35.64 | 24 |
GSM1296080 | I_lesional_pre-dose | 29.88 | 25 |
GSM1296090 | J_lesional_pre-dose | 70.1 | 37 |
GSM1296074 | K_lesional_pre-dose | 38.25 | 29 |
GSM1296111 | L_lesional_pre-dose | 87.85 | 37 |
GSM1296099 | M_lesional_pre-dose | 49.18 | 30 |
GSM1296086 | O_lesional_pre-dose | 80.15 | 39 |
GSM1296117 | P_lesional_pre-dose | 65.69 | 32 |
GSM1296113 | Q_lesional_pre-dose | 97.96 | 37 |
GSM1296096 | R_lesional_pre-dose | 62.64 | 35 |
GSM1296105 | S_lesional_pre-dose | 60.69 | 33 |
GSM1296098 | T_lesional_pre-dose | 66.35 | 33 |
GSM1296101 | U_lesional_pre-dose | 10.19 | 10 |
GSM1296121 | V_lesional_pre-dose | 59.18 | 32 |
GSM1296088 | W_lesional_pre-dose | 69.96 | 37 |
GSM1296082 | X_lesional_pre-dose | 94.99 | 42 |
GSM1296115 | Y_lesional_pre-dose | 53.21 | 30 |
GSM1296084 | Z_lesional_pre-dose | 56.03 | 32 |
GSM1296072 | B_lesional_day8 | 64.54 | 33 |
GSM1296069 | L_lesional_day8 | 75.2 | 33 |
GSM1296071 | P_lesional_day8 | 50.69 | 27 |
GSM1296070 | Y_lesional_day8 | 42.75 | 25 |
GSM1296073 | V_lesional_day8 | 37.98 | 25 |
GSM1296034 | A_lesional_day15 | 27.13 | 21 |
GSM1296041 | G_lesional_day15 | 54.19 | 30 |
GSM1296035 | R_lesional_day15 | 42.02 | 30 |
GSM1296038 | U_lesional_day15 | 30.84 | 24 |
GSM1296047 | B_lesional_day15 | 71.07 | 34 |
GSM1296039 | E_lesional_day15 | 66.45 | 35 |
GSM1296042 | H_lesional_day15 | 61.28 | 31 |
GSM1296043 | L_lesional_day15 | 70.38 | 33 |
GSM1296037 | M_lesional_day15 | 74.81 | 36 |
GSM1296046 | P_lesional_day15 | 60.73 | 30 |
GSM1296044 | Q_lesional_day15 | 80.42 | 35 |
GSM1296045 | Y_lesional_day15 | 40.57 | 23 |
GSM1296025 | C_lesional_day15 | 26.58 | 21 |
GSM1296033 | D_lesional_day15 | 49.94 | 31 |
GSM1296027 | I_lesional_day15 | 35.4 | 29 |
GSM1296032 | J_lesional_day15 | 35.98 | 26 |
GSM1296024 | K_lesional_day15 | 21.63 | 20 |
GSM1296031 | W_lesional_day15 | 74.51 | 36 |
GSM1296028 | X_lesional_day15 | 52.94 | 32 |
GSM1296029 | Z_lesional_day15 | 30.88 | 25 |
GSM1296026 | F_lesional_day15 | 18.04 | 15 |
GSM1296030 | O_lesional_day15 | 34.77 | 29 |
GSM1296040 | S_lesional_day15 | 28.85 | 22 |
GSM1296036 | T_lesional_day15 | 79.6 | 37 |
GSM1296048 | V_lesional_day15 | 44.3 | 27 |
GSM1296059 | A_lesional_day43 | 36.89 | 28 |
GSM1296066 | G_lesional_day43 | 42.88 | 26 |
GSM1296060 | R_lesional_day43 | 48.54 | 31 |
GSM1296063 | U_lesional_day43 | 66.14 | 35 |
GSM1296064 | E_lesional_day43 | 64.12 | 35 |
GSM1296067 | H_lesional_day43 | 46.78 | 27 |
GSM1296062 | M_lesional_day43 | 29.2 | 24 |
GSM1296068 | Q_lesional_day43 | 62 | 30 |
GSM1296050 | C_lesional_day43 | 60.21 | 33 |
GSM1296057 | D_lesional_day43 | 38.64 | 28 |
GSM1296052 | I_lesional_day43 | 46.41 | 32 |
GSM1296054 | J_lesional_day43 | 24.01 | 20 |
GSM1296049 | K_lesional_day43 | 24.83 | 20 |
GSM1296055 | W_lesional_day43 | 49.72 | 30 |
GSM1296053 | X_lesional_day43 | 24.53 | 21 |
GSM1296058 | Z_lesional_day43 | 28.54 | 25 |
GSM1296051 | F_lesional_day43 | 52.61 | 32 |
GSM1296056 | O_lesional_day43 | 49.98 | 33 |
GSM1296065 | S_lesional_day43 | 73.76 | 36 |
GSM1296061 | T_lesional_day43 | 26.17 | 20 |
GSM1296095 | A_non-lesional_pre-dose | 39.23 | 28 |
GSM1296120 | B_non-lesional_pre-dose | 55.45 | 30 |
GSM1296077 | C_non-lesional_pre-dose | 19.76 | 18 |
GSM1296093 | D_non-lesional_pre-dose | 26.02 | 21 |
GSM1296104 | E_non-lesional_pre-dose | ||
GSM1296079 | F_non-lesional_pre-dose | 25.7 | 20 |
GSM1296108 | G_non-lesional_pre-dose | 37.14 | 25 |
GSM1296110 | H_non-lesional_pre-dose | 66.73 | 32 |
GSM1296081 | I_non-lesional_pre-dose | 17.27 | 18 |
GSM1296091 | J_non-lesional_pre-dose | 80.33 | 39 |
GSM1296075 | K_non-lesional_pre-dose | 28.53 | 23 |
GSM1296112 | L_non-lesional_pre-dose | 81.66 | 34 |
GSM1296100 | M_non-lesional_pre-dose | 17.13 | 16 |
GSM1296087 | O_non-lesional_pre-dose | 44.2 | 31 |
GSM1296118 | P_non-lesional_pre-dose | 59.38 | 30 |
GSM1296114 | Q_non-lesional_pre-dose | 54.13 | 29 |
GSM1296097 | R_non-lesional_pre-dose | 32.74 | 25 |
GSM1296106 | S_non-lesional_pre-dose | 56.79 | 31 |
GSM1296102 | U_non-lesional_pre-dose | 37 | 26 |
GSM1296122 | V_non-lesional_pre-dose | 49.07 | 28 |
GSM1296089 | W_non-lesional_pre-dose | 87.67 | 38 |
GSM1296083 | X_non-lesional_pre-dose | 7.6 | 8 |
GSM1296116 | Y_non-lesional_pre-dose | 61.71 | 30 |
GSM1296085 | Z_non-lesional_pre-dose | 49.56 | 31 |